Clinical Investigation on the Efficacy and Safety of Relizema Cream in Paedriatric Patients

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 27, 2022

Primary Completion Date

June 9, 2023

Study Completion Date

June 9, 2023

Conditions
Atopic Dermatitis
Interventions
DEVICE

Relizema cram

Relizema cream is a CE marked, Class IIa medical device, dermatological cream for topical use indicated for symptomatic treatment of dermatitis and erythema. Relizema cream is indicated for the treatment of itching and flushing associated with different types of dermatitis, including atopic dermatitis.

Trial Locations (1)

Unknown

Luca Stingeni, Perugia

All Listed Sponsors
lead

Relife S.r.l.

INDUSTRY